Sana Biotechnology Inc

Healthcare · Biotechnology · —

2.90$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Sana Biotechnology Inc (SANA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 432 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SANA
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	631	565	681	619	559	501	445	362	435	417	374	432
Current Assets	280	214	321	263	210	161	113	83	162	149	112	171
Cash	168	134	177	135	127	128	96	71	103	72	84	57
Cash & Short-Term Investments	269	205	311	252	199	152	105	73	153	138	101	160
Goodwill	141	141	141	141	141	141	141	141	141	141	141	141
Intangible Assets	59	59	59	59	59	59	59	59	59	59	59	59
Total Liabilities	266	278	306	279	267	251	236	239	240	256	254	277
Current Liabilities	67	64	53	51	47	45	33	33	36	79	86	124
Short-Term Debt	13	13	13	10.0	11	13	13	14	15	15	15	15
Accounts Payable	9.9	4.1	6.1	3.8	3.0	5.2	1.0	2.3	1.9	1.7	2.1	1.4
Shareholders' Equity	366	288	375	340	292	251	209	123	195	161	119	155
Retained Earnings	-1,250	-1,338	-1,446	-1,496	-1,556	-1,605	-1,654	-1,748	-1,790	-1,849	-1,896	-1,960
Shares Outstanding	200	197	217	234	235	236	238	238	260	253	277	296

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings